2nd Quarter - Report

AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY for AMERICAN SOCIETY OF CATARACT & REFRACTIVE SURGERY

Firm
Client
Income
—
Expenses
$181,294
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare physician payment reform - adding inflation adjustment to physician payment updates under Medicare: HR 2474 - Strengthening Medicare for Patients and Providers Act Medicare physician payment reform - modifying budget neutrality requirements under the Medicare physician fee schedule: H.R. 6545 - the Physician Fee Schedule Update and Improvements Act Medicare physician payment reform - modifying budget neutrality requirements under the Medicare physician fee schedule: HR 6371 - Provider Reimbursement Stability Act of 2023 Reforming prior authorization under Medicare Advantage: S. 4532/H.R. 8702 - Improving Seniors Timely Access to Care Act Increasing Medicare-supported GME residency slots: S. 1302/H.R. 2389 - Resident Physician Shortage Reduction Act Statement for the record submitted to Senate Finance Committee: Bolstering Chronic Care through Physician Payment: Current Challenges and Policy Options in Medicare Part B Comments submitted to Senate Finance Draft Policy Proposal on Graduate Medical Education (GME) Comments submitted on Local Coverage Determination (LCD) on Minimally Invasive Glaucoma Surgery (MIGS)

LobbyistCovered position, as disclosed
MARK CRIBBEN —
AMANDA GRIMM WIEGREFE —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 2389 (118th), H.R. 6371 (118th), S. 4532 (118th), S. 1302 (118th), H.R. 8702 (118th), H.R. 6545 (118th), H.R. 2474 (118th)

Health Issues HCR

Support reauthorization of the Dr. Lorna Breen Health Care Provider Protection Act (H.R. 7153/S. 3679) Amend the Employee Retirement Income Security Act of 1974 to require a group health plan to establish an exception process to medication step-therapy protocol: S. 652/H.R. 2630 - Safe Step Act

LobbyistCovered position, as disclosed
MARK CRIBBEN —
AMANDA GRIMM WIEGREFE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 652 (118th), H.R. 2630 (118th), H.R. 7153 (118th), S. 3679 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.